Format

Send to

Choose Destination
Sci Data. 2018 Aug 14;5:180158. doi: 10.1038/sdata.2018.158.

The REMBRANDT study, a large collection of genomic data from brain cancer patients.

Author information

1
Innovation Center for Biomedical Informatics (ICBI), Georgetown University Medical Center, Washington DC 20007, USA.
2
National Cancer Institute, Rockville, MD, USA.
3
NewYork Presbyterian Hospital, New York, NY, USA.
4
Cornell Medical School, New York, NY, USA.

Abstract

The Rembrandt brain cancer dataset includes 671 patients collected from 14 contributing institutions from 2004-2006. It is accessible for conducting clinical translational research using the open access Georgetown Database of Cancer (G-DOC) platform. In addition, the raw and processed genomics and transcriptomics data have also been made available via the public NCBI GEO repository as a super series GSE108476. Such combined datasets would provide researchers with a unique opportunity to conduct integrative analysis of gene expression and copy number changes in patients alongside clinical outcomes (overall survival) using this large brain cancer study.

PMID:
30106394
PMCID:
PMC6091243
DOI:
10.1038/sdata.2018.158
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center